Cleared Traditional

K181918 - CardioInsight Cardiac Mapping System

K181918 is an FDA 510(k) clearance for CardioInsight Cardiac Mapping System, manufactured by Medtronic, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 113-day FDA review.

K181918 · Medtronic, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
113d
Days
Class 2
Risk

K181918 is an FDA 510(k) clearance for the CardioInsight Cardiac Mapping System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on November 8, 2018 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic, Inc. devices

FDA 510(k) Submission Details - K181918

510(k) Number K181918 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2018
Decision Date November 08, 2018
Days to Decision 113 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 125d · This submission: 113d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 360
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K181918.
EnSite Velocity Cardiac Mapping System v5.2, EnSite Precision Cardiac Mapping System v2.2
K183128 · Abbott · Dec 2018
AI-ECG Platform
K180432 · Shenzhen Carewell Electronics., Ltd. · Nov 2018
HemoSphere Advanced Monitor, HemoSphere Pressure Cable
K180881 · Edwards Lifesciences, LLC · Nov 2018
KODEX EPD System
K180940 · Philips Medical Systems Nederland B.V. · Oct 2018
EnSite Velocity Cardiac Mapping System v5.2, EnSite Precision Cardiac Mapping System v2.2
K182644 · Abbott · Oct 2018
Zio AT ECG Monitoring System, ZEUS System
K181502 · iRhythm Technologies, Inc. · Aug 2018